Investor Relations Home

Accuray Incorporated is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.

ARAY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.45
Change (%) Stock is Up 0.04 (0.48%)
Volume853,591
Data as of 04/15/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast
Q3 2014 Accuray Incorporated Earnings Conference Call (Live)
04/30/14 at 1:30 p.m. PT
Q3 2014 Accuray Incorporated Earnings Conference Call
Wednesday, April 30, 2014 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
IR Presentation March 2014
Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.